Literature DB >> 2350592

Electron microscopy: a contribution to further classification of acute unclassifiable childhood leukemia.

E R van Wering1, P Brederoo, J H van Dijk-de Leeuw, J van der Meulen, M B van 't Veer.   

Abstract

The ultrastructural, light microscopical and immunological features of twelve cases of acute childhood leukemia are described. Nine cases were unclassifiable by light microscopy, morphology and cytochemistry, and three were difficult to classify because of a low percentage of Sudan-Black B positive blasts. By means of electron microscopy (including peroxidase cytochemistry), two main groups were seen: 1. Acute myeloid leukemia, in which could be distinguished a) a more differentiated myeloid leukemia, b) a leukemia with megakaryoblastic involvement and c) a minimally differentiated acute myeloid leukemia with granules present and 2. lymphoblastic leukemia. One case could not be classified. The first group included two possible cases of a hybrid leukemia with CD19 or CD10 positivity as well as ultrastructural peroxidase activity. We conclude that electron microscopy aids to further classification of minimally differentiated and hybrid acute leukemias.

Entities:  

Mesh:

Year:  1990        PMID: 2350592     DOI: 10.1007/bf01736231

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  28 in total

1.  Perinuclear peroxidatic activity in erythroblasts.

Authors:  T Koike; R Nagayama; M Takahashi; A Hattori; A Shibata
Journal:  Br J Haematol       Date:  1986-11       Impact factor: 6.998

2.  Ultrastructural localization of peroxidase activity in developing neutrophil granulocytes from human bone marrow.

Authors:  P Brederoo; J van der Meulen; W T Daems
Journal:  Histochemistry       Date:  1986

3.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

4.  Characterizing "difficult" acute leukemias. A combined electron microscopic and immunological marker study.

Authors:  J W Hewson; K F Bradstock; A Kerr; R G Rose
Journal:  Pathology       Date:  1986-01       Impact factor: 5.306

5.  Philadelphia chromosome-positive blastic leukaemia: ultrastructural and ultracytochemical evidence of basophil and mast cell differentiation.

Authors:  J L Parkin; R W McKenna; R D Brunning
Journal:  Br J Haematol       Date:  1982-12       Impact factor: 6.998

6.  Acute leukaemia with mixed lymphoid and myeloid phenotype.

Authors:  C H Pui; G V Dahl; S Melvin; D L Williams; S Peiper; J Mirro; S B Murphy; S Stass
Journal:  Br J Haematol       Date:  1984-01       Impact factor: 6.998

7.  Expression of immunological markers on leukemic cells before and after cryopreservation and thawing.

Authors:  L Campos; D Guyotat; A Larese; E Archimbaud; L Mazet; A Ehrsam; D Fiere
Journal:  Cryobiology       Date:  1988-02       Impact factor: 2.487

8.  Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases.

Authors:  F Lampert; J Harbott; W D Ludwig; C R Bartram; J Ritter; V Gerein; M Neidhardt; R Mertens; N Graf; H Riehm
Journal:  Blut       Date:  1987-06

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.

Authors:  J Mirro; T F Zipf; C H Pui; G Kitchingman; D Williams; S Melvin; S B Murphy; S Stass
Journal:  Blood       Date:  1985-11       Impact factor: 22.113

View more
  1 in total

Review 1.  The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts.

Authors:  M B van't Veer
Journal:  Ann Hematol       Date:  1992-04       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.